Literature DB >> 12167114

Clinical characteristics and natural history of patients with low-grade reflux esophagitis.

Noriaki Manabe1, Masaharu Yoshihara, Atsunori Sasaki, Shinji Tanaka, Ken Haruma, Kazuaki Chayama.   

Abstract

BACKGROUND AND AIM: Although the incidence of reflux esophagitis (RE) has recently increased in Japan, the majority of these cases are mild (Los Angeles classification grades A and B). In order to consider therapy for these patients, it is important to understand the natural history of mild RE. There is little information concerning the natural course of RE, particularly low-grade disease. The goal of this study is to elucidate the natural course of patients with mild RE and to identify specific prognostic indicators associated with a poor outcome.
METHODS: One hundred and five patients with mild RE were followed, without medical treatment, by endoscopy in addition to a questionnaire regarding symptomatology, for a mean of 5.5 years (range, 2.0-8.8 years) after initial diagnosis. Factors associated with the development of severe esophagitis were analyzed.
RESULTS: Endoscopically, 11 patients (10.5%) progressed to more severe forms of RE (recurrent progressive (RP) group), 60.0% of patients relapsed without disease progression (recurrent non-progression group), and the remaining 29.5% of patients had no further episodes of RE (isolated episode group). Risk factors for progressive disease were increased age, female sex, the presence of symptoms at initial diagnosis by endoscopy, presence of a hiatal hernia, absence of atrophic gastritis, and absence of Helicobacter pylori infection. Despite having all risk factors, there were six patients who did not progress to more severe forms of RE. The primary esophageal peristaltic amplitude in these patients was significantly higher than in the RP group.
CONCLUSIONS: Among patients with mild RE, only 10.5% progressed to more severe forms of RE. The patients with risk factors are candidates for aggressive therapy in order to prevent the progression of the RE disease process. Copyright 2002 Blackwell Publishing Asia Pty Ltd

Entities:  

Mesh:

Year:  2002        PMID: 12167114     DOI: 10.1046/j.1440-1746.2002.02783.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  17 in total

1.  Natural history and new conceptual framework of gastroesophageal reflux disease.

Authors:  Hiroto Miwa
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

2.  Clinical characteristics of asymptomatic esophagitis.

Authors:  Tsukasa Nozu; Hiroaki Komiyama
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

3.  Erosive esophagitis in asymptomatic subjects: risk factors.

Authors:  Fu-Wei Wang; Ming-Shium Tu; Hung-Yi Chuang; Hsien-Chung Yu; Lung-Chih Cheng; Ping-I Hsu
Journal:  Dig Dis Sci       Date:  2009-08-14       Impact factor: 3.199

4.  Alginates: From the ocean to gastroesophageal reflux disease treatment.

Authors:  Serhat Bor; İsmail Hakkı Kalkan; Altay Çelebi; Dinç Dinçer; Filiz Akyüz; Peter Dettmar; Hasan Özen
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852

5.  Role of gastric acid secretion in the pathogenesis of Barrett's esophageal cancer in a Japanese population.

Authors:  Tomoyuki Koike; Shuichi Ohara; Tooru Shimosegawa
Journal:  Clin J Gastroenterol       Date:  2009-05-02

6.  Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions--a debate: pro.

Authors:  Tomás Navarro-Rodriguez; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

7.  Nonerosive Reflux Disease (NERD) - An Update.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

Review 8.  Strategy for treatment of nonerosive reflux disease in Asia.

Authors:  Toru Hiyama; Masaharu Yoshihara; Shinji Tanaka; Ken Haruma; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

Review 9.  Epidemiology and clinical characteristics of GERD in the Japanese population.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-04-14       Impact factor: 7.527

10.  Impact of PPIs on patient focused symptomatology in GERD.

Authors:  Abr Thomson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.